Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ)

CUSIP: 29446K106

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
66,704,586
Total 13F shares
35,287,993
Share change
+7,459,175
Total reported value
$54,667,551
Put/Call ratio
23%
Price per share
$1.55
Number of holders
36
Value change
+$11,793,365
Number of buys
23
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 29446K106?
CUSIP 29446K106 identifies EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Adage Capital Management, L.P.
13D/G
10%
6,012,624
$8,596,850 $0 30 Sep 2025
ADAR1 Capital Management, LLC
13F
Company
8.3%
5,559,988
$7,950,783 30 Sep 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
8%
5,329,416
$7,621,065 30 Sep 2025
13F
Decheng Capital LLC
13F
Company
6.7%
4,447,308
$6,359,650 30 Sep 2025
13F
Woodline Partners LP
13F 13D/G
Company
5.9%
from 13D/G
3,508,771
$5,017,543 30 Sep 2025
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
3%
2,003,648
$2,865,217 30 Sep 2025
13F
STEMPOINT CAPITAL LP
13F
Company
2.9%
1,908,935
$2,729,777 30 Sep 2025
13F
TAKEDA PHARMACEUTICAL CO LTD
13F
Company
2.7%
1,824,977
$2,609,717 30 Sep 2025
13F
VANGUARD GROUP INC
13F
Company
2%
1,313,946
$1,878,943 30 Sep 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.92%
614,923
$879,340 30 Sep 2025
13F
CANTOR FITZGERALD, L. P.
13F
Individual
0.64%
425,000
$607,750 30 Sep 2025
13F
Aberdeen Group plc
13F
Company
0.57%
379,526
$542,722 30 Sep 2025
13F
Ikarian Capital, LLC
13F
Company
0.5%
332,297
$475,185 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.47%
310,819
$444,528 30 Sep 2025
13F
DIADEMA PARTNERS LP
13F
Company
0.45%
300,000
$429,000 30 Sep 2025
13F
Hudson Bay Capital Management LP
13F
Company
0.42%
278,538
$398,309 30 Sep 2025
13F
STATE STREET CORP
13F
Company
0.21%
137,520
$196,654 30 Sep 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.2%
133,004
$190,196 30 Sep 2025
13F
BlackRock, Inc.
13F
Company
0.19%
126,053
$180,256 30 Sep 2025
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.19%
124,823
$178,494 30 Sep 2025
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.18%
121,953
$174,393 30 Sep 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.13%
85,557
$122,347 30 Sep 2025
13F
Persistent Asset Partners Ltd
13F
Company
0.1%
68,991
$98,657 30 Sep 2025
13F
Jason A. Keyes
3/4/5
Chief Financial Officer
class O/S missing
126,633
$82,311 14 Feb 2025
AlphaCore Capital LLC
13F
Company
0.08%
52,345
$74,853 30 Sep 2025
13F
MARSHALL WACE, LLP
13F
Company
0.06%
41,220
$58,946 30 Sep 2025
13F
Engineers Gate Manager LP
13F
Company
0.06%
39,739
$56,827 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
0.05%
35,019
$50,077 30 Sep 2025
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.04%
28,300
$40,469 30 Sep 2025
13F
UBS Group AG
13F
Company
0.04%
28,030
$40,083 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.04%
24,356
$34,829 30 Sep 2025
13F
Virtu Financial LLC
13F
Company
0.04%
23,779
$34,000 30 Sep 2025
13F
Joel Rothman
3/4/5
Chief Development Officer
mixed-class rows
233,150
mixed-class rows
$33,727 02 Jan 2024
Apollon Wealth Management, LLC
13F
Company
0.02%
13,875
$19,841 30 Sep 2025
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.02%
10,544
$15,078 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.02%
10,085
$14,422 30 Sep 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
6,406
$9,160 30 Sep 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0%
1,922
$2,000 30 Sep 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
1,000
$1,430 30 Sep 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
445
$636 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
274
$392 30 Sep 2025
13F
Rise Advisors, LLC
13F
Company
0%
263
$376 30 Sep 2025
13F
FMR LLC
13F
Company
0%
200
$286 30 Sep 2025
13F
Bala S. Manian
3/4/5
Director
mixed-class rows
40,000
mixed-class rows
21 May 2025
Barbara Troupin
3/4/5
Director
mixed-class rows
40,000
mixed-class rows
21 May 2025
Charles Douglas McDermott
3/4/5
Director
mixed-class rows
40,000
mixed-class rows
21 May 2025
Mark Pruzanski
3/4/5
Director
mixed-class rows
40,000
mixed-class rows
21 May 2025
Martha J. Demski
3/4/5
Director
mixed-class rows
40,000
mixed-class rows
21 May 2025
Peter Colabuono
3/4/5
Director
class O/S missing
20,000
21 May 2025
Ph.D. Yu Xu
3/4/5
Director
class O/S missing
20,000
22 May 2024

Institutional Holders of Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ) as of Q4 2025

As of 31 Dec 2025, Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,287,993 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, ADAR1 Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Decheng Capital LLC, Woodline Partners LP, Aberdeen Group plc, Balyasny Asset Management L.P., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and CANTOR FITZGERALD, L. P.. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
40
Q4 2025 holders
36
Holder diff
-4
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .